Montelukast Sodium Market Expected to Reach $773.78 Million by 2032, Growing at a CAGR of 11.4%

by

Market Overview:

The global montelukast sodium market has shown substantial growth over recent years, driven by the rising prevalence of respiratory disorders such as asthma and allergic rhinitis. In 2023, the market was valued at USD 293.80 million and is projected to grow from USD 326.71 million in 2024 to USD 773.78 million by 2032, exhibiting a robust compound annual growth rate (CAGR) of 11.4% during the forecast period. The increasing demand for anti-inflammatory and anti-allergy medications is one of the key factors fueling market expansion.

Market Drivers

Several factors are driving the growth of the montelukast sodium market:

  1. Rising Incidence of Respiratory Diseases: The increasing prevalence of conditions like asthma, allergic rhinitis, and bronchospasms is boosting the demand for montelukast sodium-based drugs.
  2. Growing Awareness About Allergy Management: Greater awareness regarding the management of respiratory and allergic conditions is leading to higher prescription rates for montelukast sodium.
  3. Expansion of the Pharmaceutical Sector: The pharmaceutical industry’s ongoing expansion, especially in emerging economies, is contributing to increased production and availability of montelukast sodium medications.
  4. Increased Regulatory Approvals: Regulatory bodies such as the US FDA are approving new drugs and formulations, making montelukast sodium more accessible in global markets. For example, in December 2021, Morepen Laboratories received FDA approval to market its anti-allergy drug Fexofinadine Hydrochloride in the US, strengthening its product line, including montelukast sodium.
  5. Advancements in Drug Delivery Mechanisms: The development of innovative drug delivery systems, including chewable tablets and granule formulations, is enhancing patient compliance and expanding market reach.

Some of the major players operating in the global market include:

  • Apotex Inc. (Canada)
  • Aurobindo Pharma Ltd. (India)
  • Cipla Ltd. (India)
  • Glenmark Pharmaceutical Ltd. (India)
  • Jubilant Life Sciences Ltd. (India)
  • Merck & Co. Inc. (US)
  • Mylan N.V. (US)
  • Sandoz International GmbH (Germany)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceutical Industries Ltd. (Israel)

Market Growth Trends

Several trends are shaping the future of the montelukast sodium market:

  1. Increased Focus on Generic Drug Production

The expiration of patents for branded montelukast sodium products has led to an increase in generic alternatives, making the drug more affordable and widely available.

  1. Expansion in Emerging Markets

Developing countries, particularly in Asia-Pacific and Latin America, are witnessing increased access to healthcare services, contributing to higher demand for respiratory medications.

  1. Integration with Combination Therapies

Montelukast sodium is increasingly being integrated into combination therapies alongside antihistamines to improve treatment outcomes for allergy and asthma patients.

  1. Adoption of Digital Health Solutions

The integration of digital health technologies, such as telemedicine and e-prescriptions, is enhancing the accessibility of montelukast sodium prescriptions, further driving market growth.

  1. Growing Investment in R&D

Pharmaceutical companies are investing in research and development to improve the efficacy and safety of montelukast sodium formulations, leading to more effective treatment options.

Market Challenges

Despite its positive growth trajectory, the montelukast sodium market faces certain challenges:

  • Potential Side Effects and Safety Concerns: Studies have indicated potential neuropsychiatric side effects, including mood changes and depression, which could impact patient adherence and regulatory scrutiny.
  • Stringent Regulatory Frameworks: Regulatory approvals for new formulations can be time-consuming and costly, posing challenges for market entry.
  • Availability of Alternative Therapies: The presence of alternative treatments such as corticosteroids and biologics may limit the growth of montelukast sodium.
  • Patent Expirations and Market Competition: The expiration of patents for leading branded montelukast sodium drugs has resulted in intensified competition from generic manufacturers, affecting profit margins.

Regional Analysis:

Montelukast Sodium Market, Regional Outlook (Revenue – USD Million, 2019-2032)

    • North America
      • Product Type Outlook
        • Montelukast Sodium Amorphous
        • Montelukast Sodium Crystalline
      • Dosage Form Outlook
        • Tablets
        • Chewable Tablets
        • Oral Solutions
      • Application Outlook
        • Asthma
        • Allergic Rhinitis Urticaria
        • Others
    • Europe
      • Product Type Outlook
        • Montelukast Sodium Amorphous
        • Montelukast Sodium Crystalline
      • Dosage Form Outlook
        • Tablets
        • Chewable Tablets
        • Oral Solutions
      • Application Outlook
        • Asthma
        • Allergic Rhinitis Urticaria
        • Others

This section of the research report provides an analysis of the geographic landscape of the Montelukast Sodium Market. It covers several aspects like industry share, gross margin and growth rate for all the major regions of the industry. By going through the regional analysis section, businesses can better understand the needs and wants of their target market. Also, it enables companies to make informed decisions about the products or services they’re providing. Furthermore, the research report provides an in-depth analysis of all the major sub-regions for a comprehensive understanding of the market.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:

https://www.polarismarketresearch.com/industry-analysis/montelukast-sodium-market

Opportunities in the Market

Despite these challenges, numerous opportunities exist within the montelukast sodium market:

  1. Expansion of Over-the-Counter (OTC) Availability

Increasing regulatory approvals for OTC sales of montelukast sodium can drive higher consumer adoption.

  1. Strategic Collaborations and Partnerships

Pharmaceutical companies are engaging in mergers, acquisitions, and partnerships to strengthen their foothold in the market and expand their product portfolios.

  1. Personalized Medicine and Precision Therapeutics

Advancements in pharmacogenomics and personalized medicine could lead to more targeted and effective use of montelukast sodium.

  1. Growing Demand for Pediatric Medications

Montelukast sodium is widely prescribed for children suffering from asthma and allergic rhinitis, presenting an opportunity for pediatric-focused formulations and marketing strategies.

  1. Sustainability Initiatives in Pharmaceutical Manufacturing

Adoption of eco-friendly and sustainable manufacturing practices can enhance brand reputation and compliance with evolving regulatory standards.

Conclusion:

The global montelukast sodium market is poised for significant growth, driven by increasing respiratory disorders, expanding healthcare access, and advancements in drug formulations. While challenges such as regulatory constraints and safety concerns exist, opportunities in OTC availability, digital health, and personalized medicine are expected to fuel further expansion. With ongoing research and strategic industry developments, the montelukast sodium market remains a vital component of the global pharmaceutical landscape.

Table of Contents:

  1. Global Montelukast Sodium Market Insights
    4.1. Montelukast Sodium Market – Application Snapshot
    4.2. Montelukast Sodium Market Dynamics
    4.2.1. Drivers and Opportunities
    4.2.1.1. Growing geriatric population to drive market growth
    4.2.1.2. Change in dietary habits and rapid urbanization to spur market growth
    4.2.2. Restraints and Challenges
    4.2.2.1. Side effects associated with montelukast
    4.3. Porter’s Five Forces Analysis
    4.3.1. Bargaining Power of Suppliers (Moderate)
    4.3.2. Threats of New Entrants: (Low)
    4.3.3. Bargaining Power of Buyers (Moderate)
    4.3.4. Threat of Substitute (Moderate)
    4.3.5. Rivalry among existing firms (High)
    4.4. PESTEL Analysis
    4.5. Montelukast Sodium Market Application Trends
    4.6. Value Chain Analysis
    4.7. COVID-19 Impact Analysis
    5. Global Montelukast Sodium Market, by Dosage Form
    5.1. Key Findings
    5.2. Introduction
    5.2.1. Global Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    5.3. Tablets
    5.3.1. Global Montelukast Sodium Market, by Tablets, by Region, 2019-2032 (USD Million)
    5.4. Chewable Tablets
    5.4.1. Global Montelukast Sodium Market, by Chewable Tablets, by Region, 2019-2032 (USD Million)
    5.5. Oral Solutions
    5.5.1. Global Montelukast Sodium Market, by Oral Solutions, by Region, 2019-2032 (USD Million)
    6. Global Montelukast Sodium Market, by Product Type
    6.1. Key Findings
    6.2. Introduction
    6.2.1. Global Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    6.3. Montelukast Sodium Amorphous
    6.3.1. Global Montelukast Sodium Market, by Montelukast Sodium Amorphous, by Region, 2019-2032 (USD Million)
    6.4. Montelukast Sodium Crystalline
    6.4.1. Global Montelukast Sodium Market, by Montelukast Sodium Crystalline, by Region, 2019-2032 (USD Million)
    7. Global Montelukast Sodium Market, by Application
    7.1. Key Findings
    7.2. Introduction
    7.2.1. Global Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    7.3. Asthma
    7.3.1. Global Montelukast Sodium Market, by Asthma, By Region, 2019-2032 (USD Million)
    7.4. Allergic Rhinitis Urticaria
    7.4.1. Global Montelukast Sodium Market, by Allergic Rhinitis Urticaria, By Region, 2019-2032 (USD Million)
    7.5. Others
    7.5.1. Global Montelukast Sodium Market, by Others, By Region, 2019-2032 (USD Million)

Reach out to us for a consultation.

Let’s work together to start moving your business in the right direction.

Contact Us

© Linkewre

Privacy PolicyRefund PolicyTerms & Condition